Wells Fargo lowered the firm’s price target on Cinemark (CNK) to $32 from $33 and keeps an Overweight rating on the shares. The firm says its Q4 AEBITDA is moving from $188M to $129M on a lower-than-expected DBO, while it also lowers its 2026 estimate by 2%. That said, Wells likes the setup into 2026 with studios ramping production and a more diverse/robust slate.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNK:
- Cinemark management to meet with Benchmark
- Cinemark put volume heavy and directionally bearish
- How Theaters Can Protect Themselves Against a Netflix (NFLX) Acquisition of Warner Bros. Discovery
- Cinemark participates in a webinar with Roth Capital.
- Micron upgraded, PayPal downgraded: Wall Street’s top analyst calls